Overactive bladder: drug therapy versus nerve stimulation
- 1 July 2005
- journal article
- research article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 2 (7) , 310-311
- https://doi.org/10.1038/ncpuro0227
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antimuscarinics and the Overactive Detrusor—Which Is the Main Mechanism of Action?European Urology, 2003
- Muscarinic receptor subtypes and management of the overactive bladderUrology, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscleBritish Journal of Pharmacology, 2001
- LONG-TERM RESULTS OF SACRAL NERVE STIMULATION (S3) FOR THE TREATMENT OF NEUROGENIC REFRACTORY URGE INCONTINENCE RELATED TO DETRUSOR HYPERREFLEXIAJournal of Urology, 2000
- SACRAL NEUROMODULATION IN THE TREATMENT OF URGENCY-FREQUENCY SYMPTOMS: A MULTICENTER STUDY ON EFFICACY AND SAFETYJournal of Urology, 2000
- Discussion: functional role of M1, M2, and M3 muscarinic receptors in overactive bladderUrology, 2000
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- OxybutyninDrugs & Aging, 1995
- Neural Stimulation for Control of Voiding Dysfunction: A Preliminary Report in 22 Patients with Serious Neuropathic Voiding DisordersJournal of Urology, 1989